Literature DB >> 18663530

Increased pleural soluble fas ligand (sFasL) levels in tuberculosis pleurisy and its relation with T-helper type 1 cytokines.

Ferah Budak1, Esra Kunt Uzaslan, Sengül Cangür, Güher Göral, Haluk Barbaros Oral.   

Abstract

Tuberculosis (TB) pleurisy is accepted to be the best model for evaluating the local protective cellular immune response to Mycobacterium tuberculosis (MTB) since it can be spontaneously self-cured. Therefore, we aimed to evaluate the involvement of cytokines and the soluble apoptosis-modulating factors sFas and sFasL in local protective cellular immunity to MTB. Pleural fluid samples were collected from 35 patients with TB pleurisy, 39 patients with malignant pleurisy, and 14 patients with non-TB nonmalignant (n-TB n-M) pleurisy and were evaluated for the levels of several cytokines, soluble Fas (sFas), and sFas ligand (sFasL) by using ELISA. The levels of IFN-gamma, IL-12p40, IL-18, IL-8, and sFasL in TB pleurisy were significantly higher in comparison to those in the malignant pleurisy and n-TB n-M pleurisy groups. In addition, pleural sFasL levels were increased and positively correlated with IFN-gamma and IL-18 levels in TB patients. In conclusion, this study demonstrates that Th1-type-specific cellular immunity is responsible for protective immunity in TB and suggests that Fas-mediated apoptosis may be at least a part of protective immunity to tuberculosis and could be regulated by type 1 T-cell response. IFN-gamma and sFasL levels can be used as diagnostic markers for differing TB pleurisy from other pleurisies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18663530     DOI: 10.1007/s00408-008-9107-5

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  57 in total

Review 1.  Regulation of mycobacterial heat-shock protein-reactive T cells by HLA class II molecules: lessons from leprosy.

Authors:  T H Ottenhoff; J B Haanen; A Geluk; T Mutis; B K Ab; J E Thole; W C van Schooten; P J van den Elsen; R R de Vries
Journal:  Immunol Rev       Date:  1991-06       Impact factor: 12.988

2.  IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.

Authors:  R Essner; K Rhoades; W H McBride; D L Morton; J S Economou
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

3.  Interleukin-4 inhibits tumor necrosis factor-alpha-induced and spontaneous apoptosis of biomaterial-adherent macrophages.

Authors:  William G Brodbeck; Mathew S Shive; Erica Colton; Nicholas P Ziats; James M Anderson
Journal:  J Lab Clin Med       Date:  2002-02

4.  Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions.

Authors:  C C Hua; L C Chang; Y C Chen; S C Chang
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

5.  Human Mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes.

Authors:  W H Boom; R S Wallis; K A Chervenak
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

Review 6.  Immune responses to tuberculosis in developing countries: implications for new vaccines.

Authors:  Graham A W Rook; Keertan Dheda; Alimuddin Zumla
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

7.  Evaluation of polymerase chain reaction, adenosine deaminase, and interferon-gamma in pleural fluid for the differential diagnosis of pleural tuberculosis.

Authors:  M V Villegas; L A Labrada; N G Saravia
Journal:  Chest       Date:  2000-11       Impact factor: 9.410

8.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.

Authors:  J L Flynn; M M Goldstein; J Chan; K J Triebold; K Pfeffer; C J Lowenstein; R Schreiber; T W Mak; B R Bloom
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

9.  Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis.

Authors:  M Glória Bonecini-Almeida; John L Ho; Neio Boéchat; Richard C Huard; Sadhana Chitale; Howard Doo; Jiayuan Geng; Lorena Rego; Luiz Claudio Oliveira Lazzarini; Afrânio L Kritski; Warren D Johnson; Timothy A McCaffrey; José R Lapa e Silva
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  Soluble Fas in malignant pleural effusion and its expression in lung cancer cells.

Authors:  Kayo Mitani; Yasuhiko Nishioka; Kazue Yamabe; Hirohisa Ogawa; Toyokazu Miki; Hiroaki Yanagawa; Saburo Sone
Journal:  Cancer Sci       Date:  2003-03       Impact factor: 6.716

View more
  6 in total

1.  Comparative evaluation of cytokines, T-cell apoptosis, and costimulatory molecule expression in tuberculous and nontuberculous pleurisy.

Authors:  Priya Rajavelu; Supriya Pokkali; Umashankar P; Kamlesh Bhatt; P R Narayanan; Padmini Salgame; Sulochana D Das
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

2.  Plasma melatonin and urinary 6-hydroxymelatonin levels in patients with pulmonary tuberculosis.

Authors:  Esin Ozkan; Halil Yaman; Erdinc Cakir; Omer Deniz; Muzaffer Oztosun; Seyfettin Gumus; Emin Ozgur Akgul; Mehmet Agilli; Tuncer Cayci; Yasemin Gulcan Kurt; Ibrahim Aydin; Yakup Arslan; Nevin Ilhan; Necip Ilhan; Mehmet Kemal Erbil
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

3.  Increased soluble and membrane-bound PD-L1 contributes to immune regulation and disease progression in patients with tuberculous pleural effusion.

Authors:  Xue Pan; Anyuan Zhong; Yufei Xing; Minhua Shi; Bin Qian; Tong Zhou; Yongjing Chen; Xueguang Zhang
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

4.  Modulation of cell death by M. tuberculosis as a strategy for pathogen survival.

Authors:  Markos Abebe; Louise Kim; Graham Rook; Abraham Aseffa; Liya Wassie; Martha Zewdie; Alimuddin Zumla; Howard Engers; Peter Andersen; T Mark Doherty
Journal:  Clin Dev Immunol       Date:  2011-01-04

5.  Increased levels of BAFF and APRIL related to human active pulmonary tuberculosis.

Authors:  Kai Liu; Yan Zhang; Shizong Hu; Yang Yu; Qianting Yang; Dongdong Jin; Xinchun Chen; Qi Jin; Haiying Liu
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

6.  A meta-analysis of Th1 and Th2 cytokine profiles differentiating tuberculous from malignant pleural effusion.

Authors:  Yulin Zeng; Liwei Wang; Hai Zhou; Yu Qi
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.